← All trials
NCT05413148
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 5, 2022
- Primary completion
- Jul 1, 2023
- Completion date
- Dec 15, 2023
- First posted
- Jun 9, 2022
- Last posted
- Sep 7, 2022
- Enrollment
- 135
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Erciyes UniversityLead sponsor
- Erciyes UniversityOverall official - principal investigator
- Erciyes UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.